sofosbuvir articles & resources on Made-in-China.com

Hepatitis C Treatment Isn't Pretty

Jan 16, 2014

Hepatitis C treatment isn't pretty, but the dark days of weekly injections, rough side effects and no guarantee of full recovery from the liver-damaging disease may soon be over, researchers report. Two studies, both published in the Jan. ...

Tags: Health, Medicine

Sovaldi Has Been Approved to Treat Chronic Infection with Hepatitis C

Dec 26, 2013

Sovaldi (sofosbuvir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with Hepatitis C. It's considered a breakthrough medication since it's the first such drug that does not require same-time ...

Tags: Sovaldi, chronic infection, Hepatitis C

Gilead Sciences Has Received Notice of Compliance From Health Canada

Dec 19, 2013

Gilead Sciences has received notice of compliance from Health Canada for its once-daily oral nucleotide analog polymerase inhibitor Sovaldi or sofosbuvir 400mg tablets for the treatment of chronic hepatitis C or CHC infection. Sovaldi is ...

Tags: Health, Medicine, Drug

FDA Approved Sovaldi to Treat Chronic Hepatitis C Virus Infection Without Interferon

Dec 11, 2013

The U.S. Food and Drug Administration approved Sovaldi -- sofosbuvir -- to treat chronic hepatitis C virus infection without interferon, officials say. Dr. Edward Cox, director of the Office of Antimicrobial Products in the FDA's Center ...

Tags: FDA, Sovaldi, sofosbuvir, chronic hepatitis C, health

FDA Has Approved Sovaldi 400mg Tablets

Dec 10, 2013

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved Sovaldi (sofosbuvir) 400mg tablets, a once-daily oral nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (CHC) infection ...

Tags: Gilead Sciences, Chronic Hepatitis

Gilead Obtained Priority Review Status for Sofosbuvir New Drug Application

Jun 13, 2013

Biopharmaceutical company Gilead Sciences has obtained priority review status for Sofosbuvir new drug application (NDA) from the FDA for the treatment of hepatitis C infection (HCV). The investigational product is an oral nucleotide ...

Tags: Gilead, Sofosbuvir NDA